推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
特朗普访华,施展欧盟很愚蠢! 特朗普访华很得胜,但目下欧盟又尬在那了,因为他们还
关于OD
中新经纬5月18日电(董湘依)跟着好意思元体系里面实体经济的失衡,东说念主民币外
关于OD
开元棋牌官方网站入口 直播吧5月15日讯中超第12轮,北京国安主场4-2驯顺青岛
日前,国乒队员牛冠凯在酬酢平台告示喜信,晒出共创视频,与竹马之交的退役畅通员段冬
全球知谈,手机圈这两年的竞争还是到了尖锐化的进度,各家子品牌和性能线齐在拚命堆电
凡是稍稍可爱外出游玩的东说念主,齐不得不感喟我们国度的气候有多耐看。从东北漫天飞

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
type 2 diabetes with atherosclerosis相关文献:
Non-linear associations of atherogenic index of plasma with prediabetes and type 2 diabetes mellitus among Chinese adults aged 45 years and above: a cross-sectional study from CHARLS.
Jiang L, Li L, Xu Z, Tang Y, Zhai Y, Fu X, Liu D, Wu Q.
Front Endocrinol (Lausanne). 2024 Apr 2;15:1360874. doi: 10.3389/fendo.2024.1360874. eCollection 2024.
PMID:38628590
Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?
Ishii H.
J Diabetes Investig. 2022 Jul;13(7):1114-1121. doi: 10.1111/jdi.13799. Epub 2022 Apr 18.
PMID:35377559
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.
Kaur R, Kaur M, Singh J.
Cardiovasc Diabetol. 2018 Aug 31;17(1):121. doi: 10.1186/s12933-018-0763-3.
PMID:30170601
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.
Moon JS, Park IR, Kim SS, Kim HS, Kim NH, Kim SG, Ko SH, Lee JH, Lee I, Lee BK, Won KC.
Diabetes Metab J. 2023 Nov;47(6):818-825. doi: 10.4093/dmj.2023.0171. Epub 2023 Nov 24.
PMID:38043782
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.
Low Wang CC, Hess CN, Hiatt WR, Goldfine AB.
Circulation. 2016 Jun 14;133(24):2459-502. doi: 10.1161/CIRCULATIONAHA.116.022194.
PMID:27297342
Neuroprotective Effect of SGLT2 Inhibitors.
Pawlos A, Broncel M, Woźniak E, Gorzelak-Pabiś P.
Molecules. 2021 Nov 28;26(23):7213. doi: 10.3390/molecules26237213.
PMID:34885795
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.
Yang YS, Kim HL, Kim SH, Moon MK.
Diabetes Metab J. 2023 Jan;47(1):1-9. doi: 10.4093/dmj.2022.0448. Epub 2023 Jan 20.
PMID:36727160
Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus.
Abdaly MS, Azizi MS, Wijaya IP, Nugroho P, Purnamasari D.
Acta Med Indones. 2019 Apr;51(2):169-176.
PMID:31383833
Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
Venkatapuram S, Shannon RP.
Am J Ther. 2006 Jan-Feb;13(1):64-71. doi: 10.1097/00045391-200601000-00011.
PMID:16428924
Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs.
Kärberg K, Forbes A, Lember M.
Medicina (Kaunas). 2023 Jul 18;59(7):1324. doi: 10.3390/medicina59071324.
PMID:37512134
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3